Molina Healthcare — Oct 22, 2025 release

Within that guidance, the Company expects Medicaid to contribute a gain of approximately $3.00 per diluted share, but is expected to be offset by a loss of approximately $2.65 per diluted share due to anticipated performance in Medicare and Marketplace. Guidance metrics are summarized below: Full Year 2025 Guidance Premium Revenue $42.5B Total Revenue $44.5B GAAP Net Income $630M Adjusted Net Income $742M GAAP EPS – Diluted ~ $11.90 Adjusted EPS – Diluted ~ $14.00 Diluted weighted average shares 53.0M MCR 91.3% Medicaid 91.5% Medicare 91.3% Marketplace 89.7% GAAP G&A Ratio 6.6% Adjusted G&A Ratio 6.5% Effective Tax Rate 21.7% GAAP Pre-tax Margin 1.8% Adjusted Pre-tax Margin 2.1% See the Reconciliations of Unaudited Non-GAAP Financial Measures at the end of this release. 2026 Outlook While the Company expects to provide formal 2026 guidance on its fourth quarter and fiscal year 2025 earnings call, the preliminary 2026 outlook for adjusted earnings per share is expected to approximate the full year 2025 guidance. This initial outlook includes reduced exposure to Marketplace, with segment earnings at least break even. -MORE- Molina Healthcare, Inc. Reports Third Quarter 2025 Financial Results Page 4 October 22, 2025 Conference Call Management will host a conference call and webcast to discuss Molina Healthcare’s third quarter results for the period ended September 30, 2025, at 8:00 a.m. Eastern Time on Thursday, October 23, 2025. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 266091